Evaluating the cost-benefit profile of CPI stem cell therapy necessitates a comprehensive perspective. Proponents often highlight the potential for meaningful therapeutic outcomes, principally in conditions where conventional therapies have proven limited. However, crucially important to consider the significant financial expenditure associated wit